Literature DB >> 7631613

Hypotension during dobutamine stress echocardiography: is it related to dynamic intraventricular obstruction?

S K Heinle1, F D Tice, J Kisslo.   

Abstract

Although it has been shown that a hypotensive response during dobutamine stress echocardiography is not a marker of coronary artery disease, the mechanism of this response remains unclear. We hypothesize that hypotension during dobutamine stress echocardiography is not related to the development of dynamic intraventricular obstruction. The development of left ventricular outflow obstruction was defined as a late-peaking Doppler velocity profile that exceeded baseline outflow velocity by at least 1 m/sec in 104 consecutive patients undergoing dobutamine stress echocardiography. Left ventricular outflow obstruction was seen in 13% of 15 patients with a hypotensive response (group 1) and in 13% of 89 patients without a hypotensive response (group 2). The mean baseline systolic blood pressure was 157 +/- 21 mm Hg in group 1 compared to 139 +/- 25 mm Hg in group 2 (p = 0.008). An ischemic response to dobutamine infusion as manifested by the development of new or worsening wall motion abnormalities was seen in 40% of group 1 patients and 34% of group 2 patients (p = 0.77). These data demonstrate that a hypotensive response is not related to the development of dynamic intraventricular obstruction during dobutamine stress echocardiography. Rather, there is a significant association between a higher baseline systolic blood pressure and a hypotensive response during dobutamine infusion.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7631613     DOI: 10.1016/0002-8703(95)90446-8

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  1 in total

1.  Dobutamine stress echocardiography for assessing the role of dynamic intraventricular obstruction in left ventricular ballooning syndrome.

Authors:  Mario Previtali; Rita Camporotondo; Alessandra Repetto; Stefania Panigada
Journal:  Cardiovasc Ultrasound       Date:  2010-04-09       Impact factor: 2.062

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.